Probiotec Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Probiotec Limited with three other
pharmaceutical manufacturers in Australasia:
sales of 5.29 million Australian Dollars [US$3.63 million]
of which 12%
(4.36 million Australian Dollars [US$3.00 million]
AFT Pharmaceuticals Ltd
based in New Zealand
(85.13 million New Zealand Dollars [US$53.91 million]
of which 59%
Probiotec Limited reported sales of A$79.09 million (US$54.28 million)
June of 2019.
increase of 4.4%
versus 2018, when the company's sales were A$75.72 million.